...
首页> 外文期刊>Indian journal of nephrology >Drug-induced acute interstitial nephritis: A clinicopathological study and comparative trial of steroid regimens
【24h】

Drug-induced acute interstitial nephritis: A clinicopathological study and comparative trial of steroid regimens

机译:药物性急性间质性肾炎:类固醇疗法的临床病理研究和比较试验

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Steroids are used in the management of drug-induced acute interstitial nephritis (AIN). The present study was undertaken to compare the efficacy of pulse methyl prednisolone with oral prednisolone in the treatment of drug-induced AIN. Patients with biopsy-proven AIN with a history of drug intake were randomized to oral prednisolone (Group 1) 1 mg/kg for 3 weeks or a pulse methyl prednisolone (Group II) 30 mg/kg for 3 days followed by oral prednisolone 1 mg/kg for 2 weeks, tapered over 3 weeks. Kidney biopsy scoring was done for interstitial edema, infiltration and tubular damage. The response was reported as complete remission (CR) (improvement in estimated glomerular filtration rate [eGFR] to ≥60 ml/min/1.73 m2), partial remission (PR) (improvement but eGFR <60 ml/min/1.73 m2) or resistance (no CR/PR). A total of 29 patients, Group I: 16 and Group II: 13 were studied. Offending drugs included nonsteroidal anti-inflammatory drugs, herbal drugs, antibiotics, diuretic, rifampicin and omeprazole. There was no difference in the baseline parameters between the two groups. The biopsy score in Groups I and II was 5.9 ± 1.1 and 5.1 ± 1.2, respectively. At 3 months in Group I, eight patients each (50%) achieved CR and PR. In Group II, 8 (61%) achieved CR and 5 (39%) PR. This was not significantly different. Percentage fall in serum creatinine at 1 week (56%) was higher in CR as compared to (42%) those with PR. (P = 0.14). Patients with neutrophil infiltration had higher CR compared to patients with no neutrophil infiltration (P = 0.01). Early steroid therapy, both oral and pulse steroid, is equally effective in achieving remission in drug-induced AIN.Keywords: Acute interstitial nephritis, estimated glomerular filtration rate, nonsteroidal anti-inflammatory drugs
机译:类固醇用于治疗药物性急性间质性肾炎(AIN)。本研究旨在比较脉冲甲基泼尼松龙与口服泼尼松龙在治疗药物性AIN中的疗效。经活检证实具有药物摄入史的AIN患者随机分为口服泼尼松龙(第1组)1 mg / kg,持续3周;或脉冲甲基泼尼松龙(第II组),30 mg / kg,持续3天,然后口服泼尼松龙1 mg / kg 2周,逐渐减少3周。进行肾活检评分以检查间质水肿,浸润和肾小管损伤。据报道,该反应为完全缓解(CR)(估计肾小球滤过率[eGFR]提高到≥60ml / min / 1.73 m2),部分缓解(PR)(改善但eGFR <60 ml / min / 1.73 m2)或电阻(无CR / PR)。共研究了29名患者,第一组:16名,第二组:13名。令人讨厌的药物包括非甾体抗炎药,草药,抗生素,利尿剂,利福平和奥美拉唑。两组之间的基线参数没有差异。第一和第二组的活检评分分别为5.9±1.1和5.1±1.2。在第一组的3个月中,每位8名患者(50%)达到了CR和PR。在第二组中,有8名(61%)达到了CR,有5名(39%)达到了PR。这没有明显的不同。 1周时,血清肌酐的下降百分比(56%)在CR患者中比在PR患者中更高(42%)。 (P = 0.14)。与没有中性粒细胞浸润的患者相比,中性粒细胞浸润的患者具有更高的CR(P = 0.01)。早期的类固醇疗法(口服和脉冲类固醇)在缓解药物诱导的AIN方面同样有效。关键词:急性间质性肾炎,估计的肾小球滤过率,非甾体抗炎药

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号